Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New protease inhibitor to be tested in multicenter trial

Aug. 24, 1999

Additional preclinical studies of HE-2000 begin in nonhuman primates

Aug. 23, 1999

Chiron initiates phase III study of Proleukin for HIV

Aug. 23, 1999

Remune clinical trial commences in South America

Aug. 16, 1999

Improved NNRTIs reported by Medivir in patent literature

Aug. 16, 1999

Sulfated oligosaccharide glycosides with anti-HIV activity described by Japanese team

Aug. 13, 1999

CPMP adopts positive opinion concerning reformulated Norvir capsules

Aug. 13, 1999

Bristol-Myers Squibb identifies an optimized salt of a potent anti-HIV drug candidate

Aug. 12, 1999

MAb 1F7 making steady progress toward clinical testing stage

Aug. 12, 1999

Amerimmune to begin phase I/II study of AIDS drug in September

Aug. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...